Provided by Tiger Trade Technology Pte. Ltd.

CapsoVision, Inc.

5.83
-0.1900-3.16%
Post-market: 5.830.00000.00%16:10 EDT
Volume:77.03K
Turnover:456.41K
Market Cap:290.56M
PE:-9.34
High:6.18
Open:6.05
Low:5.82
Close:6.02
52wk High:15.37
52wk Low:3.43
Shares:49.84M
Float Shares:28.65M
Volume Ratio:0.79
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6241
EPS(LYR):-1.0309
ROE:-335.06%
ROA:-132.47%
PB:22.07
PE(LYR):-5.66

Loading ...

Company Profile

Company Name:
CapsoVision, Inc.
Exchange:
NASDAQ
Establishment Date:
2005
Employees:
99
Office Location:
18805 Cox Avenue,Suite 250,Saratoga,California,United States
Zip Code:
95070
Fax:
408 370 4795
Introduction:
CapsoVision, Inc. was incorporated under the laws of Delaware on August 1, 2005, as "Capso Vision, Inc." and changed its name to CapsoVision, Inc. on May 31, 2016. The company is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence technologies deployed in its capsule endoscopy solutions for identifying gastrointestinal abnormalities for diagnostic and screening purposes.

Directors

Name
Position
Chen Lung Tsai
Chairman
Kang HuaiWang
President, Chief Executive Officer and Director
Joanne Imperial
Independent Director
Julia Gouw
Independent Director
Michele Harari
Independent Director
Wen Herng Henry King
Independent Director
Hui Ying Kuo
Director

Shareholders

Name
Position
Kang HuaiWang
President, Chief Executive Officer and Director
David Garcia
Principal Financial Officer and Principal Accounting Officer
Douglas Atkinson
Head of Global Sales
Keri Jorgenson
Director of Clinical Operations